Enveric Biosciences, Inc.
ENVB
$1.22
$0.010.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.15M | -2.08M | -1.88M | -2.46M | -3.44M |
| Total Depreciation and Amortization | 82.50K | 84.80K | 84.80K | 85.40K | 84.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 883.30K | 370.20K | 351.00K | 330.10K | 1.39M |
| Change in Net Operating Assets | 877.30K | 701.90K | -1.45M | -556.90K | 205.80K |
| Cash from Operations | -1.31M | -927.10K | -2.89M | -2.60M | -1.75M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 483.80K | 517.80K | 64.50K | 4.98M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20.40K | -100.00 | -30.10K | 1.67M | -186.10K |
| Cash from Financing | 463.40K | 517.70K | 34.40K | 6.66M | -186.10K |
| Foreign Exchange rate Adjustments | -22.60K | 18.50K | 1.30K | 8.10K | -41.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -870.70K | -390.90K | -2.85M | 4.07M | -1.98M |